Skip to main content
. 2017 Jan 17;13(3):1807–1810. doi: 10.3892/ol.2017.5605

Table I.

Patient characteristics.

Characteristic Patient 1 Patient 2
Age at diagnosis, years 57 62
Primary tumor staging cT3cN0M0 cTxcN1M0
Histology Squamous cell carcinoma Adenocarcinoma
Primary treatment Chemoradiotherapy followed by surgery Chemoradiotherapy (surgery not indicated due to comorbidities)
Disease-free interval, months 18 21
Site of recurrence Lower neck lymph nodes Neck lymph nodes
Number of fractions of SBRT 5 5
Dose prescribed, Gy 30 40
Prescription isodose, % 65 81
Maximum dose, Gy 45.9 49.2
Dose gradient (Paddick) 0.17 0.12
Conformity index (ICRU 83) 0.91 0.88
Maximum dose to trachea, Gy 32.6 Not applicable
Maximum dose to major blood vessels, Gy 35.4 45.7
Maximum dose to esophagus, Gy 27 Not applicable

SBRT, stereotactic body radiotherapy; ICRU, International Commission on Radiation Units.